STVN NYSE
Credit Risk of going bust: lower than 64% of companies Debt: 8.4% of company value Bonds: none of note held by US funds details ▾
Total debt $493.1M against a stock market value of $5.36B.
Distance to default 6.73 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $306.8M (short-term plus half of long-term), stock volatility 44.9%; Altman Z'' 4.21. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Piombino Dese, PD 35017
IT
Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Stocchi Mauro | S-Sale | 13,649 | $21.50 | 2026-09-28 |
| Santel Luciano | S-Sale | 2,023 | $20.09 | 2026-08-07 |
| Dal Lago Marco | S-Sale | 4,209 | $20.09 | 2026-08-07 |
| Magistretti Elisabet | S-Sale | 2,045 | $20.09 | 2026-08-07 |
| MOREL DONALD E JR | S-Sale | 1,493 | $17.09 | 2026-06-15 |